Booster Vaccination Against COVID-19

PHASE2CompletedINTERVENTIONAL
Enrollment

222

Participants

Timeline

Start Date

July 12, 2021

Primary Completion Date

March 9, 2022

Study Completion Date

June 6, 2022

Conditions
COVID-19Sars-CoV-2 Infection
Interventions
BIOLOGICAL

CoronaVac

One dose vaccine will be administered to subjects who have passed at least 90 days and at most 270 days after the second dose of the first course of CoronaVac vaccine.

BIOLOGICAL

Turkovac

One dose vaccine will be administered to subjects who have passed at least 90 days and at most 270 days after the second dose of the first course of CoronaVac vaccine.

Trial Locations (4)

Unknown

Ankara City Hospital Internal Medicine Clinic, Ankara

Sancaktepe Martyr Professor Dr. İlhan Varank Training and Research Hospital Infectious Diseases and Clinical Microbiology Clinic, Istanbul

T.R. Ministry of Health Kartal Dr. Lütfi Kirdar City Hospital Infectious Diseases, Istanbul

Ümraniye Training and Research Hospital Infectious Diseases, Istanbul

All Listed Sponsors
lead

Health Institutes of Turkey

OTHER_GOV